Cynthia Kwan
3801 University St
Montreal, QC, Canada
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Concurrent mGlu2-mGlu4 receptor positive allosteric modulation for L-DOPA-induced treatment-induced complications in the parkinsonian marmoset.
Journal: Pharmacology, biochemistry, and behavior
Published: December 14, 2025
The anti-dyskinetic effect of the clinic-ready mGluR2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 24, 2024
Positive allosteric mGluR2 modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 09, 2024
Activation of mGlu 2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism.
Journal: Behavioural pharmacology
Published: April 02, 2024
Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 21, 2024
Effect of the mGlu2 positive allosteric modulator biphenyl-indanone A as a monotherapy and as adjunct to a low dose of L-DOPA in the MPTP-lesioned marmoset.
Journal: The European journal of neuroscience
Published: January 18, 2024
[3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain.
Journal: Experimental brain research
Published: January 06, 2024
Effect of the mGlu4 positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.
Journal: Psychopharmacology
Published: April 20, 2023
The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset.
Journal: The European journal of neuroscience
Published: April 19, 2023
Metabotropic glutamate receptors in Parkinson's disease.
Journal: International review of neurobiology
Published: March 03, 2023
Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset.
Journal: European journal of pharmacology
Published: September 26, 2022
The mGluR2/3 orthosteric agonist LY-404,039 reduces dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 14, 2022
Last Updated: 09/26/2026